Racemic-Dobutamine
Racemic-Dobutamine Brand names, Racemic-Dobutamine Analogs
Racemic-Dobutamine Brand Names Mixture
- No information avaliable
Racemic-Dobutamine Chemical_Formula
C18H23NO3
Racemic-Dobutamine RX_link
http://www.rxlist.com/cgi/generic3/dobutamine.htm
Racemic-Dobutamine fda sheet
Racemic-Dobutamine msds (material safety sheet)
Racemic-Dobutamine Synthesis Reference
No information avaliable
Racemic-Dobutamine Molecular Weight
301.38 g/mol
Racemic-Dobutamine Melting Point
No information avaliable
Racemic-Dobutamine H2O Solubility
No information avaliable
Racemic-Dobutamine State
Solid
Racemic-Dobutamine LogP
3.489
Racemic-Dobutamine Dosage Forms
Liquid
Racemic-Dobutamine Indication
For inotropic support in the short- term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures
Racemic-Dobutamine Pharmacology
Dobutamine is a direct-acting inotropic agent whose primary activity results from stimulation of the beta-adrenoceptors of the heart while producing comparatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects. Dobutamine acts primarily on beta-1 adrenergic receptors, with little effect on beta-2 or alpha receptors. It does not cause the release of endogenous norepinephrine, as does dopamine. Dobutamine is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.
Racemic-Dobutamine Absorption
No information avaliable
Racemic-Dobutamine side effects and Toxicity
No information avaliable
Racemic-Dobutamine Patient Information
No information avaliable
Racemic-Dobutamine Organisms Affected
Humans and other mammals
